In an exciting development, UNIDO ITPO Bahrain will join as strategic advisers for the 2025 awards programme, further ...
Meanwhile, Sage reported failed phase 2 trials of dalzanemdor in Alzheimer's, Parkinson's, and Huntington's disease, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback